Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$63.83 - $80.0 $1,085 - $1,360
-17 Reduced 0.53%
3,186 $205,000
Q1 2022

Apr 25, 2022

BUY
$76.85 - $89.45 $21,979 - $25,582
286 Added 9.8%
3,203 $248,000
Q4 2021

Jan 25, 2022

SELL
$74.57 - $87.19 $24,682 - $28,859
-331 Reduced 10.19%
2,917 $250,000
Q3 2021

Oct 21, 2021

BUY
$73.77 - $83.61 $8,778 - $9,949
119 Added 3.8%
3,248 $261,000
Q2 2021

Jul 19, 2021

SELL
$80.5 - $88.01 $6,198 - $6,776
-77 Reduced 2.4%
3,129 $252,000
Q1 2021

Apr 19, 2021

SELL
$76.38 - $86.03 $5,652 - $6,366
-74 Reduced 2.26%
3,206 $270,000
Q4 2020

Jan 14, 2021

SELL
$75.39 - $82.36 $3,392 - $3,706
-45 Reduced 1.35%
3,280 $263,000
Q2 2020

Jul 28, 2020

SELL
$78.66 - $94.14 $4,719 - $5,648
-60 Reduced 1.77%
3,325 $286,000
Q1 2020

Apr 20, 2020

SELL
$71.57 - $93.3 $1,073 - $1,399
-15 Reduced 0.44%
3,385 $275,000
Q4 2019

Jan 27, 2020

SELL
$76.7 - $88.45 $2,301 - $2,653
-30 Reduced 0.87%
3,400 $284,000
Q3 2019

Oct 16, 2019

BUY
$81.4 - $89.78 $4,395 - $4,848
54 Added 1.6%
3,430 $300,000
Q2 2019

Jul 08, 2019

BUY
$73.44 - $82.41 $247,933 - $278,216
3,376 New
3,376 $276,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.